ES2029114T5 - Un metodo para medir la fraccion libre de ligandos en fluidos biologicos. - Google Patents

Un metodo para medir la fraccion libre de ligandos en fluidos biologicos.

Info

Publication number
ES2029114T5
ES2029114T5 ES89300062T ES89300062T ES2029114T5 ES 2029114 T5 ES2029114 T5 ES 2029114T5 ES 89300062 T ES89300062 T ES 89300062T ES 89300062 T ES89300062 T ES 89300062T ES 2029114 T5 ES2029114 T5 ES 2029114T5
Authority
ES
Spain
Prior art keywords
ligand
antibody
ligands
biological fluids
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89300062T
Other languages
English (en)
Other versions
ES2029114T3 (es
Inventor
John Edward Maurice Midgley
Christopher Peter Sheehan
Nicos Demetriou Christofides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Amersham International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27516786&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2029114(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham International PLC filed Critical Amersham International PLC
Publication of ES2029114T3 publication Critical patent/ES2029114T3/es
Application granted granted Critical
Publication of ES2029114T5 publication Critical patent/ES2029114T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

UN ENSAYO EN UNA ETAPA DE LA PARTE LIBRE DE UN LIGANDO EN UNA MUESTRA BIOLOGICA INCLUYE LA INCUBACION DE UNA MEZCLA DE LA MUESTRA CON UN ANTICUERPO MARCADO PARA EL LIGANDO Y UN ANALOGO DE LIGANDO QUE COMPITE CON EL LIGANDO PARA ENLAZAR EL ANTICUERPO. EL ENSAYO SE CARACTERIZA POR USAR UN ANTICUERPO MONOCLONAL Y POR ELEGIR UN ANALOGO DE LIGANDO QUE TIENE UNA AFINIDAD POR EL ANTICUERPO INFERIOR A LA DEL LIGANDO. UN ANALOGO DEL LIGANDO INSOLUBILIZADO PREFERIBLEMENTE TIENE UNA AFINIDAD LIGANTE POR EL ANTICUERPO DE 0,01-10 % DE LA DEL LIGANDO. EJEMPLOS DE PARES LIGANDOÑANALOGO DE LIGANDO SON T4/T3 (TIROXINA/TRIYODOTIRONINA); TESTOSTERONA/ETIOCOLANOL; Y T3/T2
ES89300062T 1988-01-08 1989-01-05 Un metodo para medir la fraccion libre de ligandos en fluidos biologicos. Expired - Lifetime ES2029114T5 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB888800419A GB8800419D0 (en) 1988-01-08 1988-01-08 Method for measuring free fraction of ligands in biological fluids
US47396490A 1990-04-17 1990-04-17
US55158090A 1990-07-02 1990-07-02
US88507092A 1992-05-18 1992-05-18
US08/022,416 US5278080A (en) 1988-01-08 1993-02-11 Method for measuring the free fraction of ligands in biological fluids

Publications (2)

Publication Number Publication Date
ES2029114T3 ES2029114T3 (es) 1992-07-16
ES2029114T5 true ES2029114T5 (es) 2001-04-16

Family

ID=27516786

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89300062T Expired - Lifetime ES2029114T5 (es) 1988-01-08 1989-01-05 Un metodo para medir la fraccion libre de ligandos en fluidos biologicos.

Country Status (12)

Country Link
US (1) US5278080A (es)
EP (1) EP0324540B2 (es)
JP (1) JP2718229B2 (es)
AT (1) ATE64469T1 (es)
AU (1) AU619712B2 (es)
CA (1) CA1340536C (es)
DE (1) DE68900106D1 (es)
ES (1) ES2029114T5 (es)
FI (1) FI92884C (es)
GB (1) GB8800419D0 (es)
WO (1) WO1989006363A1 (es)
ZA (1) ZA8918B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3626468A1 (de) * 1986-08-05 1988-02-11 Hoechst Ag Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten
DE3727238A1 (de) * 1987-08-14 1989-02-23 Henning Berlin Gmbh Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen
US5364796A (en) * 1989-07-11 1994-11-15 Pb Diagnostics Systems, Inc. Diagnostic assay system
IT1254858B (it) * 1992-04-14 1995-10-11 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.
DE4214922C2 (de) * 1992-05-06 1996-06-13 Brahms Diagnostica Gmbh Verfahren zur quantitativen Bestimmung des Anteils der freien Form eines Schilddrüsenhormon-Liganden in einer biologischen Flüssigkeit und Kit zur Durchführung eines solchen Verfahrens
EP0606950A3 (en) * 1993-01-13 1995-07-12 Eastman Kodak Co Method for determining the reaction rate of analytes.
AU4117696A (en) * 1994-11-24 1996-06-17 Unipath Limited Recovery of and uses of specific binding agents
DE19504198A1 (de) * 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
US6143578A (en) * 1996-05-10 2000-11-07 Bayer Corporation Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
US5888835A (en) * 1996-05-10 1999-03-30 Chiron Diagnostics Corporation Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
ATE250768T1 (de) * 1996-07-18 2003-10-15 Dade Behring Marburg Gmbh Reagentien für tests für mycophenolsäure
US6087088A (en) * 1997-01-31 2000-07-11 Bayer Corporation Binding assays using more than one label for determining analyte in the presence of interfering factors
WO2010013525A1 (ja) * 2008-07-31 2010-02-04 日東紡績株式会社 複合体の測定方法およびそれに用いるキット
JP5997446B2 (ja) * 2011-02-03 2016-09-28 アークレイ株式会社 甲状腺ホルモン固定化担体の液体試薬およびその用途
CN114544831B (zh) * 2022-02-21 2024-05-10 成都翼泰生物科技有限公司 分离血液中游离甲状腺激素的方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292296A (en) * 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method
US4366143A (en) * 1979-09-24 1982-12-28 Amersham International Public Limited Company Assay for the free portion of substances in biological fluids
WO1983003306A1 (en) * 1982-03-19 1983-09-29 Roger Philip Ekins Method and composition for free ligand assays
EP0089806B1 (en) * 1982-03-22 1989-06-28 AMERSHAM INTERNATIONAL plc Assay for the free portion of substances in biological fluids
ZA837119B (en) * 1982-10-07 1984-12-24 Amersham Int Plc Assay for the free portion of substances in biological fluids
GB2134806B (en) 1983-02-07 1986-07-16 English Clays Lovering Pochin A tube pressure filter
GB8408193D0 (en) * 1984-03-30 1984-05-10 Cambridge Patent Dev Antibodies
DE3727238A1 (de) * 1987-08-14 1989-02-23 Henning Berlin Gmbh Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen

Also Published As

Publication number Publication date
AU2925189A (en) 1989-08-01
ES2029114T3 (es) 1992-07-16
EP0324540B2 (en) 2000-12-27
GB8800419D0 (en) 1988-02-10
JP2718229B2 (ja) 1998-02-25
EP0324540A1 (en) 1989-07-19
FI92884C (fi) 1995-01-10
CA1340536C (en) 1999-05-11
EP0324540B1 (en) 1991-06-12
JPH03502243A (ja) 1991-05-23
FI92884B (fi) 1994-09-30
DE68900106D1 (de) 1991-07-18
AU619712B2 (en) 1992-01-30
ATE64469T1 (de) 1991-06-15
US5278080A (en) 1994-01-11
WO1989006363A1 (en) 1989-07-13
ZA8918B (en) 1989-10-25
FI903348A0 (fi) 1990-07-03

Similar Documents

Publication Publication Date Title
ES2029114T3 (es) Un metodo para medir la fraccion libre de ligandos en fluidos biologicos.
FI903515A0 (fi) Testimenetelmä ja reagenssikitti sitä varten
ATE58600T1 (de) Testverfahren.
ATE82072T1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DE3877617D1 (de) Verfahren zum erreichen einer linearen normkurve in einem sandwich-immunoassay.
DE3779704D1 (de) Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten.
JPS6428560A (en) Immunometric measurement
DE3650437D1 (de) Verfahren zum Messen von Freiliganden in biologischen Flüssigkeiten.
EP0274198A3 (en) Immuno assays
ES2042661T3 (es) Procedimiento de determinacion inmunologico para la determinacion de sustancias libres que poseen propiedades hapteno.
ATE22997T1 (de) Verfahren zur immunologischen bestimmung, unter verwendung zweier antikoerper, wobei der zweite antikoerper durch affinitaetschromatographie gereinigt ist, und traeger dafuer.
DE69323244D1 (de) Immunotests unter Verwendung von markierten Thyronin-Analogen
IT1237809B (it) Metodo per la determinazione qualitativa e quantitativa di anticorpi diretti contro antigeni batterici attraverso la misurazione fotometrica dell'agglutinazione.
HUT53230A (en) Method for radioimmunological detecting prostaglandin e down 2 content

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 324540

Country of ref document: ES